CLINICAL_TRIALS
withdrawal
· 2017-08-01
Clinical Trial Update: Cyclooxygenase-2 Expression in Tissue Samples From Patients With a Normal Cervix, Cervical Intraepithelial Neoplasia, or Early Invasive Cervical Cancer
Summary
Wake Forest University Health Sciences sponsored a study evaluating cyclooxygenase-2 expression in cervical tissue from normal cervix through cervical intraepit…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Wake Forest University Health Sciences | Conditions: Cervical Cancer, Precancerous Condition | Status: WITHDRAWN